What we're reading, February 10, 2016: 2 companies change how consumers purchase medicines online; CMS memo reveals the government is mulling changes to Medicare reimbursement; and Johns Hopkins will transplant HIV-positive organs to HIV-positive recipients.
Transparency is often cited as one of the best ways lower drug prices, and now 2 companies are pulling back the curtain to change how consumers purchase medicines. In a new article, The New York Times highlighted GoodRx, which collects drug prices and connects consumers with coupons, and Blink Health, which allows consumers to purchase drugs online and pick them up at nearly any pharmacy. The price quotes on these sites are for generic drugs, but they cannot help much with brand-name drugs.
A new memo from CMS has revealed that there may be changes coming for how Medicare pays physicians. However, the document has since been taken down from CMS’ website, and its release called “premature,” reported Bloomberg Business. According to the memo, a new payment system would allow reimbursement to doctors for the drugs they administer to vary by geographic location.
Johns Hopkins will become the first hospital in the United States to transplant organs from HIV-positive donors to HIV-positive recipients. Until recently, such use of organs from HIV-positive individuals was illegal in the US, but South Africa has been allowing these transplants for several years with positive outcomes, according to The Washington Post. The US passed a law in late 2013 legalizing the use of HIV-positive organs for HIV-positive recipients.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More